A high percentage of unrecognized myocardial infarctions (UMIs) seen at delayed-enhanced magnetic resonance imaging (DE-MRI) are not detected by ECG. DE-MRI-detected UMIs are independent predictors of cardiovascular events in patients with coronary artery disease. In an elderly population, subjects with DE-MRI-detected UMIs do not have increased Framingham risk score or increased prevalence of artery stenosis in whole-body MR angiography as patients with recognized myocardial infarctions (RMI). Further investigation on the pathogenesis of DE-MRI-detected UMIs focus on the need to decide the management of these subjects. From the Prospective Investigation of the Vasculature in Uppsala Seniors, 248 subjects underwent cardiac MRI at age 70 and from these, 185 underwent a 5-year follow-up MR. DE-MRI-detected UMIs had lower signal intensity than RMIs probably reflecting different composition of their tissues. Subjects with UMI scar had increased levels of NT-proBNP, a predictor of increased risk of cardiovascular events. After 5 years, UMI scars were in their majority seen on the same location and with the same size, and their prevalence increased. Subjects with an UMI did not differ from subjects without a scar in terms of coronary stenosis assessed by computed tomography angiography or signs of ischemia on exercise test. In conclusion, DE-MRI-detected UMI scars are a frequent finding in an elderly population and its prevalence increases with age. The increased levels of NT-proBNP indicate that subjects with an UMI might have an increased rate of future cardiovascular events but the findings that these scars might have a different contrast distribution volume on MRI and that they are not related to CAD are indicators that they probably have a different etiology from RMIs. The prognosis of DE-MRI detected UMI scars in the general population is still unknown and therefore the clinical management of these individuals is yet to be defined.

Coronary magnetic resonance angiography (CMRA) is a potential diagnostic tool for coronary artery disease (CAD). Compared to the current gold standard, x-ray angiography, CMRA provides three-dimensional visualization of coronary vessel lumens without the use of catheters and ionizing radiation. CMRA, however, requires long acquisition times that span multiple heartbeats. Typically, to reduce cardiac motion artifacts, electrocardiogram (ECG) gating is used to synchronize data acquisition windows to diastasis periods. Gating errors may cause vessel blurring by unintentionally triggering the scanner to acquire image data during periods of significant cardiac motion. This is particularly problematic for CMRA because of the associated fine spatial resolution requirement for diagnosing CAD. This thesis presents and tests the novel idea of determining the timing of global epicardial diastasis periods from the motion of the basal ventricular septum. An experiment involving a small patient cohort undergoing elective diagnostic angiography revealed a significant correlation between the beat-to-beat diastasis periods of the ventricular septum and the coronary vasculature. This motivated the ii development and testing of the hypothesis that suggests sharper coronary artery images may be obtained by using cardiac gating windows determined by septal motion. A preliminary study involving a small volunteer cohort provided encouraging results, but also revealed limitations of using ultrasound to measure septal motion during a pre- scan prior to an MRA exam. This led to the major technical development of this thesis, which is a magnetic resonance imaging (MRI) method called the Septal Scout for monitoring septal motion at a very high temporal resolution. The technique was applied to a volunteer cohort which showed that cardiac gating windows as determined by the Septal Scout provided sharper coronary images compared with conventional ECG gating. The scientific knowledge and technical developments presented in this thesis are intended to improve CMRA as a non-invasive diagnostic tool of CAD. In the future, I intend to integrate the concepts presented here into a functioning MRI-based cardiac gating system. As well, I intend to validate the Septal Scout in a patient cohort study.

Diss. (sammanfattning) Linköping : Univ., 2001. / Härtill 5 uppsatser.

BACKGROUND: Cardiovascular disease, principally manifest as myocardial infarction or stroke, is the dominant cause of death worldwide and despite therapeutic advances, the global burden of these conditions continues to increase. In order to address this ongoing disease burden, there is a clear need to more effectively target the use of existing and novel diagnostic investigations and medical therapies. Emerging cardiovascular biomarkers include the biochemical, such as high-sensitivity cardiac troponin, and the radiological, such as computed tomography coronary angiography (CTCA) and 18Ffluoride positron emission tomography (PET). Cardiac troponins can now be reliably quantified in clinically stable or asymptomatic populations and provide information about myocardial pathophysiology, whilst CTCA can non-invasively quantify atherosclerotic burden and 18F-fluoride PET imaging offers insight into plaque vulnerability. Improved targeting of diagnostic investigations requires more reliable estimation of pre-test probability of coronary disease whilst optimizing the use of pharmacological or interventional treatments requires more accurate prognostic stratification. Achieving both objectives in an equitable manner across all population groups will depend upon updated clinical guidelines containing improved risk models and enhanced management pathways. The objective of this thesis was to investigate the potential clinical benefit of novel approaches to the diagnostic and prognostic assessment of coronary heart disease. EVALUATION OF THE 2016 NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) GUIDANCE ON THE ASSESSMENT OF SUSPECTED STABLE ANGINA. A post-hoc analysis was undertaken of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial of 4,146 participants with suspected angina randomised to assessment with computed tomography coronary angiography or standard care. Patients were dichotomised according to guideline definitions into groups representing possible angina and non-anginal presentations. The primary (diagnostic) endpoint was diagnostic certainty of angina at 6 weeks and the prognostic endpoint comprised fatal and non-fatal myocardial infarction. In 3,770 eligible participants, CTCA increased diagnostic certainty more in those with possible angina (relative risk [RR] 2.22 (95% CI 1.91-2.60), p < 0.001) than those with non-anginal symptoms (RR 1.30 (1.11-1.53), p=0.002; pinteraction < 0.001). In the possible angina cohort, CTCA did not change rates of invasive angiography (p=0.481) but markedly reduced rates of normal coronary angiography (hazard ratio [HR] 0.32 (0.19-0.52), p < 0.001). In the non-anginal cohort, rates of invasive angiography increased (HR 1.82 (1.13-2.92), p=0.014) without reducing rates of normal coronary angiography (HR 0.78 (0.30-2.05), p=0.622). At 3.2 years of follow-up, fatal or nonfatal MI was reduced in patients with possible angina (3.2% to 1.9%; HR 0.58 (0.34- 0.99), p=0.045) but not in those with non-anginal symptoms (HR 0.65 (0.25-1.69), p=0.379). Overall the updated NICE guidance on patient assessment maximises the benefits of CTCA with respect to diagnostic certainty, the use of invasive coronary angiography, and reductions in fatal and non-fatal myocardial infarction. Patients with non-anginal chest pain derive minimal benefit from CTCA, which instead increases rates of invasive investigation. EXTERNAL VALIDATION OF THE PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN (PROMISE) TOOL FOR DETERMINING MINIMAL-RISK OF CORONARY ARTERY DISEASE. The PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) minimal-risk tool was recently developed to identify patients with suspected stable angina at very low risk of coronary artery disease and clinical events. The external validity of this tool was investigated within the context of the Scottish Computed Tomography of the HEART multicenter randomised controlled trial of patients with suspected stable angina due to coronary artery disease. Model discrimination and calibration was determined amongst 1,764 patients in whom complete CCTA data were available and compared with the European Society of Cardiology guideline-endorsed Coronary Artery Disease Consortium (CADC) risk score. The PROMISE minimal-risk tool improved discrimination compared with the CADC model (c-statistic 0.785 vs 0.730, p < 0.001) and was improved further following re-estimation of covariate coefficients (c-statistic 0.805, p < 0.001). Model calibration was initially poor (c2 197.6, Hosmer-Lemeshow [HL] p < 0.001), with significant overestimation of probability of minimal risk, but improved significantly following revision of the PROMISE minimal-risk intercept and covariate coefficients (c2 5.6, HL p=0.692). HIGH-SENSITIVITY CARDIAC TROPONIN I IN THE DIAGNOSIS OF STABLE CORONARY ARTERY DISEASE In a pre-specified sub-study of the Scottish COmputed Tomography of the Heart trial, plasma cardiac troponin was measured using a high-sensitivity single molecule counting assay in 943 adults with suspected stable angina who had undergone coronary computed tomography angiography. Rates of obstructive coronary artery disease were compared with the pre-test probability determined by the European Society of Cardiology Coronary Artery Disease Consortium risk model with and without cardiac troponin concentrations. External validation was undertaken in an independent study population from Denmark comprising 487 patients with suspected stable angina. Higher cardiac troponin concentrations were associated with obstructive coronary artery disease with a 5-fold increase across quintiles (9 to 48%, p < 0.001) independent of known cardiovascular risk factors (odds ratio [OR] 1.35 [95% confidence interval (CI) 1.25-1.46] per doubling of troponin). Cardiac troponin concentrations improved the discrimination of the ESC model for identifying obstructive coronary artery disease (c-statistic 0.785 to 0.800, p=0.003) and improved classification into ESCrecommended categories of clinical risk (net reclassification improvement 0.143 [95% CI, 0.093-0.193]). The revised model achieved similar improvements in discrimination and net reclassification when applied in the external validation cohort. HIGH-SENSITIVITY CARDIAC TROPONIN I IN CARDIOVASCULAR RISK STRATIFICATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND HEIGHTENED CARDIOVASCULAR RISK. The association between plasma high-sensitivity cardiac troponin I concentration and cardiovascular events in patients with chronic obstructive pulmonary disease and heightened cardiovascular risk was examined within the context of a double-blind randomised controlled trial of inhaled corticosteroids and bronchodilators (1 placebo arm and 3 different treatment arms). Plasma cardiac troponin I concentrations were measured with a high-sensitivity assay in a subgroup of 1,599 patients. The cardiovascular endpoint was a composite of cardiovascular death, myocardial infarction, stroke, unstable angina and transient ischaemic attack during follow-up of 1.5 years. Baseline plasma cardiac troponin I concentrations were above the lower limit of detection (1.0 ng/L) in 1,559 (97.5%) patients and were unaffected by inhaled therapies at 3 months (p > 0.05 for all). Compared with the lowest tertile (cardiac troponin I ≤3.0 ng/L), patients in the highest tertile (≥ 5.5 ng/L) were at greater risk of cardiovascular events (hazard ratio 3.0, 95% confidence interval 1.5 to 6.2, p=0.002) and cardiovascular death (hazard ratio 9.6, 95% confidence interval 2.6 to 35.6, p < 0.001) after adjustment for cardiovascular risk factors. There were no differences in COPD exacerbations between tertiles even after adjustment (p > 0.05). / REPRODUCIBILITY OF CORONARY 18F-FLUORIDE PET-CT IMAGING The inter-observer and scan-rescan reproducibility of coronary 18F-fluoride PET-CT imaging was investigated in 20 patients with clinically stable but high risk multi-vessel coronary artery disease who underwent repeated 18F-fluoride PET-CT scans 11.5±4.5 days apart. Scan analysis using the currently accepted approach of normalisation to a referent coronary segment (TBRREFERENT) identified 10 (50%) patients with evidence of focal coronary 18F-fluoride uptake and demonstrated moderate agreement across observers on a per-patient level (k = 0.56). This was similar to the level of agreement achieved with visual assessment alone (k = 0.64). Reproducibility was improved by semi-quantitative reporting combining visual assessment with a threshold uptake value for determining the presence of tracer uptake (k = 0.84). Using the optimised approach achieved excellent agreement on overall segmental uptake counts (intra-class correlation = 0.97). CONCLUSION: Cardiovascular diagnostic and prognostic assessments represent a complex endeavour and established tools for risk prediction can demonstrate suboptimal predictive accuracy when evaluated in patient cohorts that are independent of the population used for model derivation.

Os vasos de fino calibre apresentam maior risco para reestenose e revascularização da lesão alvo. Limitações relacionadas com a navegabilidade dos sistemas de dilatação por balão e menor capacidade de acomodação da neoíntima podem contribuir para isto. O stent autoexpansível de nitinol Sparrow® dedicado a vaso de calibre < 2,75 mm, resultou num conjunto com perfil de um fio-guia 0,014\". Testado na forma de stent de metal puro no estudo CARE I, revelou-se seguro e eficaz em vasos de fino calibre. Este estudo avaliou, de forma pioneira, o despenho de um stent autoexpansível farmacológico neste cenário. O objetivo primário foi comparar a perda luminal tardia no vaso-alvo pela angiografia coronária quantitativa ao final de oito meses, entre os stents Sparrow® farmacológico e não farmacológico, em coronárias com diâmetro de referência < 2,75 mm. Casuística e métodos: Os pacientes foram randomizados de forma prospectiva em dois grupos para procedimento de angioplastia: um grupo com o emprego o stent Sparrow® farmacológico (sirolimus), e ou outro grupo com o stent Sparrow® na versão não farmacológica. Análise pela angiografia coronária quantitativa foi realizada imediatamente antes e após o procedimento e aos oito meses, com seguimento clínico de 24 meses. Foi utilizado o programa IBM SPSS Statistics® para análise estatística e foi considerado nível de significância de 5% e poder de 80% para o cálculo do tamanho da amostra. Resultados: 24 pacientes foram randomizados, 12 no grupo com stent farmacológico Sparrow® e 12 no grupo com a versão não farmacológica. Na avaliação angiográfica aos oito meses verificou-se significativa redução de perda luminal tardia no grupo com o stent farmacológico Sparrow® em comparação com grupo com a versão não farmacológica (0,25 + 0,16 mm versus 0,97 + 0,76 mm, p = 0,008, IC 95% de -1,19 ; -0,22). No seguimento clínico de 12 meses, não foram observados eventos cardíacos adversos maiores (morte, infarto ou necessidade de revascularização do vaso alvo) no grupo com stent farmacológico. Não ocorreu trombose intrastent. Conclusão: Em pacientes submetidos à angioplastia transluminal percutânea em artérias coronárias com diâmetro de referência < 2,75 mm, o emprego do stent farmacológico autoexpansível Sparrow®, em comparação com a versão não farmacológica do mesmo stent, resultou em significativa redução de perda luminal tardia, sem ocorrência de eventos clínicos que deponham contra a segurança do dispositivo pesquisado. / Small vessels represent a group with high risk for restenosis and target lesion revascularization. Limitations associated with navigability of balloon dilation systems and less accommodating of the neointima may contribute to this. The self-expanding Sparrow® stent system dedicated to the vessel size <2.75 mm resulted in a profile similar to a 0.014\" guide wire angioplasty. Tested as bare metal stent in the CARE trial I, the Sparrow® stent system has proved to be safe and effective in small vessels. This study evaluated, for the first time, the performance of a self-expanding drug eluting stent in this scenario. The primary objective was to compare the in-stent late lumen loss by quantitative coronary angiography at the end of eight months between the Sparrow® drug-elutig stent and Sparrow® bare metal stent in coronary arteries with reference diameter <=2.75 mm. Materials and methods: Patients were prospectively randomized (1:1) Analysis by quantitative coronary angiography was performed immediately before and after the procedure and at eight months with clinical follow-up to 12 months. We used the IBM® SPSS for statistical analysis and was considered a significance level of 5% and 80% power for the calculation of sample size. Results: 24 patients were randomized, 12 in each group. At Eight months follow-up there was significant reduction in late lumen loss in the Sparrow® drug-eluting stent group compared to the Sparrow® bare metal stent group (0.25 ± 0.16 mm vs. 0.97 + 0.76 mm, p = 0.008, 95% CI -1.19 to -0.22). Up to 12 months of clinical follow-up there no cases of death, myocardial infarction and target vessel revascularization Of note, there was no stent thrombosis. Conclusion: In patients undergoing percutaneous transluminal angioplasty in coronary arteries with reference diameter <= 2.75 mm, the use of Sparrow® drug-eluting stent, compared to the Sparrow® bare metal stent, resulted in significant less late loss without occurrence of clinical events that weigh against the security of device.

INTRODUÇÃO: A cineangiocoronariografia é um procedimento médico invasivo que envolve sentimentos de medo e ansiedade. Estudos internacionais têm avaliado o efeito da música como técnica de intervenção para redução da ansiedade utilizando-a antes, durante e depois da cineangiocoronariografia. Contudo, os resultados de sua aplicação durante o procedimento não são consensuais. OBJETIVO: A proposta do presente estudo foi avaliar o efeito da música, aplicada durante a realização do procedimento, na ansiedade de pacientes submetidos à cineangiocoronariografia pela primeira vez. MÉTODOS: Os desfechos estudados foram o nível de ansiedade medido pelo Inventário de Ansiedade Beck, a frequência cardíaca e pressão arterial, ambas medidas pelo método intra-arterial. Participaram do estudo 300 pacientes randomizados entre o grupo controle (procedimento padrão) ou grupo música (cineangiocoronariografia realizada com a intervenção musical). Foi realizado o cegamento da pesquisadora durante toda a coleta e análise estatística dos dados. RESULTADOS: Os grupos eram semelhantes em relação às características de base, bem como dados sobre os hábitos musicais dos pacientes e dados da cineangiocoronariografia. Não foram observadas diferenças entre os grupos controle e música para todos os desfechos estudados: nível de ansiedade (p=0,072), pressão arterial sistólica (p=0,379), pressão arterial diastólica (p=0,152) e frequência cardíaca (p=0,853). Notou-se também que, mesmo antes da realização do procedimento, 80,9% do grupo controle e 76,9% do grupo música já apresentavam o menor nível de ansiedade (mínima). As mulheres mostraram-se mais ansiosas do que os homens (p=0,000 pré-exame e p=0,022 pós-exame). Não houve relação na comparação entre ansiedade e diferentes faixas etárias (p=0,352 pré-exame, p=0,198 pós-exame). CONCLUSÃO: A música aplicada no presente estudo durante a cineangiocoronariografia não se mostrou efetiva na redução dos níveis de ansiedade, pressão arterial e frequência cardíaca dos pacientes submetidos ao procedimento pela primeira vez. Constatou-se também que as mulheres são mais ansiosas do que os homens e que não houve relação entre o nível de ansiedade e faixas etárias / BACKGROUND: Coronary angiography is an invasive medical procedure that involves feelings of fear and anxiety. International studies have evaluated the effects of music intervention to reduce anxiety by using it before, during and after coronary angiography. However, the results of this strategy are not clear. OBJECTIVE: The aim of this study was to evaluate the effect of music, employed during the procedure, on anxiety of patients undergoing coronary angiography for the first time. METHODS: Outcomes were anxiety level measured by the Beck Anxiety Inventory, heart rate and blood pressure, both measured by intra-arterial method. The study included 300 patients randomized between the control group (standard procedure) or music group (standard procedure with a music intervention). The researcher was blinded throughout the data collection and statistical analysis. RESULTS: Baseline variables were adequatly balanced between both groups, as well as data on musical habits and coronary angiography. No differences were observed between the control group and music group in any of the outcomes: level of anxiety (p = 0.072), systolic blood pressure (p = 0.379), diastolic blood pressure (p = 0.152) and heart rate (p = 0.853). It was also noted that even before the procedure, 80.9% of the control group and 76.9% of the music group had low level of anxiety. Women were more anxious than men (p = 0.000 pre-test and p = 0.022 post-test). No relationship was found between anxiety and age (p = 0.352 pre-test, p = 0.198 post-test). CONCLUSION: The music used in this study during coronary angiography was not effective in reducing anxiety levels, blood pressure or heart rate in patients undergoing the procedure for the first time. It was also found that women are more anxious than men and that there was no relationship between anxiety levels and age

A angiografia coronariana por tomografia computadorizada (ACTC) é um exame bem estabelecido no diagnóstico da doença arterial coronariana. Entretanto, segmentos coronarianos submetidos a implante de stent podem apresentar limitação na avaliação luminal. O objetivo deste estudo é avaliar o valor adicional da perfusão miocárdica por tomografia computadorizada (PMTC) à avaliação anatômica isolada pela ACTC em portadores de stent, tendo o cateterismo (CATE) como referência. Quarenta e seis pacientes (56,9±7,2 anos, 28 homens) com indicação clínica de CATE em até 60 dias foram submetidos à avaliação combinada de ACTC e PMTC, por meio de tomógrafo de 64 detectores (Aquillion 64, Toshiba). A aquisição foi iniciada com a fase de estresse (PMTC) usando-se dipiridamol a 0,56mg/kg/4min e 60ml de contraste a 3ml/s, seguido de reversão com aminofilina 240mg e metoprolol (até 20mg). Em seguida, realizou-se a ACTC com 80-90ml de constraste a 5ml/s. Os dados da PMTC, da ACTC, e do CATE foram analisados por dois observadores independentes, sem informações clínicas dos pacientes. Primariamente analisou-se a ACTC, seguida da avaliação da PMTC. Concluída esta fase, os observadores tinham a possibilidade de reclassificar os segmentos coronarianos submetidos a stent cuja avaliação estivesse limitada ou inadequada por artefatos. A dose total média de radiação foi 15,83±4,93 mSv e todos os exames foram adequados. Um total de 129 segmentos coronarianos foi avaliado na ACTC, bem como os respectivos territórios miocárdicos pela PMTC. Destes, 54 territórios (42%) eram relacionados à presença de stents, sendo 19 com stents de avaliação adequada e 23 com avaliação luminal limitada, porém possível, e 12 segmentos de avaliação inadequada (sem possibilidade de avaliação luminal). Os valores de sensibilidade, especificidade, valor preditivo positivo, valor preditivo negativo e acurácia para a ACTC isolada nos territórios com stents foram de, respectivamente: 85%, 76%, 85%, 76% e 81%, e com o uso combinado da ACTC + PMTC foram de, respectivamente 88%, 95%, 97%, 83% e 92% (p=0,0314). Nos territórios com stent e avaliação luminal prejudicada (limitada ou inadequada) os valores para análise da ACTC isolada foram de, respectivamente: 83%, 71%, 75%, 80% e 77% e após a análise da ACTC + PMTC foram de, respectivamente: 89%, 94%, 94%, 89% e 92% (p = 0,0441). A avaliação combinada da ACTC + PMTC permitiu melhorar a acurácia diagnóstica da avaliação de obstrução coronariana significativa em pacientes portadores de stents, comparativamente à avaliação isolada da ACTC / Coronary computed tomography angiography (coronary CTA) is a well established examination in the diagnosis of coronary artery disease (CAD). However, the segments with prior coronary stent implantation may have limited luminal evaluation. The aim of this study is to assess the incremental value of myocardial computed tomography perfusion (myocardial CTP) to the anatomical assessment by coronary CTA alone in patients with stents, using catheterization (CAT) as a reference method. Forty-six patients (56.9 ± 7.2 years, 28 men) referred to CAT by clinical indication within 60 days, were evaluated with combined evaluation of coronary CTA and myocardial CTP through 64-detector CT scanner (Aquillion 64, Toshiba). The acquisition protocol began with the stress phase (myocardial CTP), using dipyridamole to 0.56 mg/kg/4min and 60ml of contrast (3ml/s), followed by a bolus of aminophylline 240 mg and metoprolol (up to 20mg). After, it was performed the coronary CTA wih 80-90ml of contrast (5 ml/s). Data from the myocardial CTP, coronary CTA and CAT were analyzed by two independent observers, with no knowledge to clinical information. The observers reviewed the coronary CTA findings, and in a second time performed the evaluation of myocardial CTP. So, they had the possibility to reclassify segments with coronary stent that were considered with limited or inadequate assessment due to artifacts. Mean total dose of radiation was 15.83 ± 4.93 mSv, and all examinations were interpretable. A total of 129 coronary segments were evaluated by coronary CTA, and also were their correspondent myocardial territories by myocardial CTP. Of these, 54 territories (42%) were related to the presence of stents, 19 stents with adequate evaluation, 23 with limited evaluation, but possible, and 12 with inadequate evaluation (no luminal assessment possible). The sensitivity, specificity, positive predictive value, negative predictive value and accuracy for the coronary CTA in territories with stents were respectively: 85%, 76%, 85%, 76% and 81%, and the combined use of coronary CTA + Myocardial CTP were respectively 88%, 95%, 97%, 83% and 92% (p=0.0314). In territories with impaired luminal stent evaluation (limited or inadequate), the values for analysis of coronary CTA alone were: 83%, 71%, 75%, 80% and 77%, and after analysis of myocardial CTP were, respectively: 89%, 94%, 94%, 89% and 92% (p = 0.0441). The combined evaluation of the coronary CTA and myocardial CTP has improved the diagnostic accuracy of the evaluation of significant coronary obstruction in patients with stents, compared to the assessment of coronary CTA alone

Kardiovaskulär sjukdom är den dominerande folksjukdomen i världen och därför genomgår många personer en kranskärlsröntgen i diagnostiskt syfte. Att utredas för en sjukdom kan leda till både fysiska och psykiska reaktioner hos personer. Både i Hälso- och sjukvårdslagen och i Patientlagen finns ett starkt krav på självbestämmande. För att patienten ska ha möjlighet att utöva självbestämmande och vara delaktig i vården är inflytande och information från vårdpersonal avgörande. Att arbeta personcentrerat ökar personens förmåga att ta till sig information och den ökade delaktigheten kan göra dessa individer mer förberedda både inför sin undersökning och även inför en framtida diagnos. Syftet var att undersöka fysiska och psykiska hälsoeffekter av information och utbildning hos patienter i samband med en planerad kranskärlsröntgen. Metoden var en allmän litteraturöversikt med systematisk metod. Sökord kombinerades och artikelsökningar utfördes i databaserna CINAHL och PubMed samt via manuella sökningar. Femton kvantitativa studier inkluderades i litteraturöversikten. De kvalitetsbedömdes och sammanställdes i en artikelmatris. Artiklarna analyserades via integrerad analys där likheter och skillnader identifierades. I resultatet framträdde två huvudkategorier: fysiska och psykiska hälsoeffekter. De fysiska hälsoeffekterna fick underkategorierna effekt på patientens vitala parametrar och förändringar i procedurrelaterad smärta. Underkategorierna till de psykiska hälsoeffekterna var effekt på patientens oro/ångest, stress och depression, tolerans och trygghet under kranskärlsröntgen, patientens tillfredsställelse med utbildningen och informationen samt påverkan på patientens följsamhet och livsstil. Slutsatsen var att utbildning och information i olika former medförde positiva hälsoeffekter såsom minskad procedurrelaterad smärta samt ökad tillfredsställelse och trygghet. Även bättre följsamhet till instruktioner och en mer positiv attityd till livsstilsförändringar noterades. När det gällde oro och ångest samt effekt på vitalparametrar sågs olika resultat. Majoriteten av studierna uppvisade minskad oro och ångest av information och utbildning, några visade ingen skillnad och en studie uppvisade förvärrad oro och ångest i samband med kranskärlsröntgen. Gällande effekten på vitalparametrar framkom varierande resultat med minskad eller ingen effekt av utbildningsinterventionerna. / Cardiovascular disease is the predominant public disease in the world. Therefore, many people undergo a coronary angiography for risk assessment. To be screened for a diagnosis can lead cause both physical and psychological stress reactions for the person being screened. Both the Health Care Act and the Patient Act have a strong requirement for bodily autonomy. To facilitate for the patient having bodily autonomy and being involved in care, influence and information from the health care staff are crucial. Person-centered care increases the person's ability to assimilate information and shared decision-making can make these individuals more prepared both for their examination and for a future diagnosis. The aim was to investigate the physical and psychological health effects of information and education to patients scheduled for a coronary angiography. The method was a general literature review with a systematic method. Keywords were combined and article searches were performed in the CINAHL and PubMed databases as well as via manual searches. Fifteen quantitative studies were included in the literature review. They were quality assessed and compiled in an article matrix. The articles were analyzed via integrated analysis where similarities and differences were identified. In the result, two main categories emerged: physical and psychological health effects. The physical health effects had the subcategories effect on the patient's vital parameters and changes in procedure-related pain. The subcategories of the psychological health effects were the effect on the patient's anxiety, stress and depression, tolerance and comfort during the coronary angiography, the patient's satisfaction with the education and information and the impact on the patient's adherence and lifestyle. The conclusion was that the literature review showed a positive effect of education and information in various forms in connection with the coronary angiography, such as reduced procedure-related pain, increased satisfaction and comfort. Better adherence to instructions and a more positive attitude towards lifestyle changes were also noted. Different results were identified with regards to anxiety and the effect on vital parameters. The majority of the studies showed reduced anxiety while a few studies showed no difference and one study indicated increased anxiety. The effect on vital parameters varied between reduced effect or no effect of the education interventions.

Bakgrund: Misstanke om angina är vanligt förekommande, och utreds ofta med kranskärlsröntgen. Det är visserligen känns att dessa patienter lider av oro, ovisshet och försämrad livskvalitet men kunskap behövs om varför patienter blir besvikna över ett normalt undersökningsfynd. Syfte: Syftet med studien var att beskriva upplevelser hos patienter som uttrycker en besvikelse över att kranskärlsröntgen visar normala kärl eller inte förklarar patientens symtom samt beskriva vad känslan av besvikelse grundar sig i. Metod: En empirisk studie med beskrivande design och kvalitativ ansats. Sju semistrukturerade intervjuer utfördes med patienter med misstänkt angina. Data har analyserats med kvalitativ innehållsanalys. Huvudresultat: Deltagarna uttryckte en besvikelse över att inte få veta vad deras besvär beror på och över att kranskärlsröntgen inte visade på något som behövde och kunde åtgärdas, vilket hade kunnat bidra till förbättrat välbefinnande och en förbättrad fysisk förmåga. Deltagarna beskrev en förlust och saknad över att inte kunna leva det aktiva liv som de gjort tidigare, vilket tolkas ligga till grund för de förväntningar och reaktioner som deltagarna uttrycker. Upplevda begränsningar, oro och ovisshet leder till psykisk lidande, i form av frustration, nedstämdhet, uppgivenhet, och en känsla av hopplöshet. Detta leder till förväntningar på att få svar och hopp om åtgärd. Slutsats: Sjukvården kanske inte alltid kan minska patienternas grad av begränsningar, men genom relevant och anpassad information, kan vi ge patienterna rimliga förväntningar och till viss del kanske minska graden av besvikelse. Genom tydliga besked, stöd, och uppföljning kan vi förhoppningsvis minska patienternas psykiska lidande och känsla av ovisshet. / Background: Suspicion of angina are common, and often investigated with coronary angiography. Although it´s known that these patients suffer from anxiety, uncertainty and impaired QoL, knowledge is needed as to why patients are disappointed with normal examination findings. Aim: The aim of this study was to describe experiences in patients who express disappointment over the fact that coronary angiography shows normal vessels or don´t explain the patient's symptoms, and to describe what the feeling of disappointment is based on. Method: An empirical study with descriptive design and qualitative approach. Seven semi-structured interviews were conducted with patients with suspected angina. Data have been analyzed with qualitative content analysis. Main results: The participants expressed disappointment of not knowing what causes their problems and that coronary angiography did not reveal something that needed or could be fixed, which could have contributed to improved well-being and improved physical ability. The participants described a loss of not being able to live the active life that they´ve been used to, which interpreted to be the cause of their expressed expectations and reactions. Their experienced limitations, anxiety and uncertainty lead to mental suffering, frustration, depression, despair, and a feeling of hopelessness. This leads to expectations of getting answers and hope of treatment. Conclusion: Healthcare may not always be able to reduce patients' degree of limitation, but through relevant and customized information, we can give patients reasonable expectations and to some extent perhaps reduce the degree of disappointment. Through clear messages, support, and follow-up, we can hopefully reduce patients' mental suffering and feelings of uncertainty.

Objectives: To compare early coronary angiography to a delayed or selective approach in out‐of‐hospital cardiac arrest (OHCA) without ST‐segment elevation of possible cardiac cause by means of meta‐analysis of available randomized controlled trials (RCTs). Methods: We searched MEDLINE and the Cochrane Central Register of Controlled Trials for RCTs comparing early with delayed or selective coronary angiography in OHCA patients of possible cardiac origin without ST‐segment elevation. The primary endpoint was all‐cause short‐term mortality (PROSPERO CRD42021271484). Results: The search strategy identified three RCTs enrolling a total of 1167 patients. An early invasive approach was not associated with improved short‐term mortality (odds ratio 1.19, 95% confidence interval 0.94–1.52; p = 0.15). Further, no significant differences were shown with respect to the risk of severe neurological deficit, the composite of all‐cause mortality or severe neurological deficit, need for renal replacement therapy due to acute renal failure, and significant bleeding at short‐term follow‐up. Conclusion: Early coronary angiography in OHCA without ST‐segment elevation is not superior compared to a delayed/selective approach.